Fast Five Quiz: Breast Cancer Treatment

Figure 1. Colored MRI of a section through a 58-year-old woman's left breast, showing a malignant adenocarcinoma (tumor, dark) and tissue damage.

Tumor gene-expression assays can determine the likelihood of recurrence in early-stage breast cancer and thus the potential benefit of adjuvant chemotherapy. Lower scores indicate a prognostic recurrence rate that is unlikely to be improved by adjuvant chemotherapy. A higher score, however, can be predictive of chemotherapy benefit. Adjuvant therapy involves radiation and systemic therapy, which includes a variety of chemotherapeutic, hormonal, and biologic agents.

Needle biopsy, mammogram, and MRI are all tools that may be used in the diagnosis of breast cancer.

Learn more about determining the potential benefit of adjuvant chemotherapy for breast cancer.

Medscape © 2021 WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Pavani Chalasani. Fast Five Quiz: Breast Cancer Treatment - Medscape - Jul 12, 2021.